Lead investigator Linda Anne Feagins, MD, assistant professor in the Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, and clinician at the Dallas Veterans Administration Medical Center, said the risk of discontinuing the drug exceeds the risk of bleeding. About 6 percent of stent thromboses in patients who discontinued clopidogrel occurred within 10 days.
Current ASGE guidelines recommend clinicians consider discontinuing clopidogrel seven to 10 days before elective polypectomy in patients who are at high risk for bleeding.
Related Articles about Colonoscopy:
Women Can Wait Longer Than Men to Start Colonoscopies, Study Finds
Dr. Douglas Rex Discusses Future of Screening Colonoscopy
Fatalistic Attitude Toward Cancer Key Factor in Low Screening Rates
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
